Dave Hering, Invivyd CEO

In­vivyd re­quests emer­gency use au­tho­riza­tion for Covid-19 pre­ven­tive an­ti­body among im­muno­com­pro­mised

In­vivyd has asked the FDA for an emer­gency use au­tho­riza­tion for its Covid-19 pre-ex­po­sure pre­ven­tion an­ti­body, the Mass­a­chu­setts-based biotech an­nounced Wednes­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.